Or. Admin. R. 415-020-0070 - Medical Services

Current through Register Vol. 61, No. 4, April 1, 2022

(1) There shall be at least one program physician, licensed nurse practitioner or licensed physicians' assistant available to supervise the initial medical evaluation, supervise follow-up care and to supervise the patient medication schedules, who is licensed under the appropriate State law and registered under the appropriate State and Federal laws to order narcotic drugs for patients.
(2) The licensed physician, licensed nurse practitioner or licensed physicians' assistant assumes responsibility for the amounts of narcotic drugs administered or dispensed and shall record and countersign all changes in the dosage schedule.
(3) Licensed nurse practitioners or licensed physicians' assistants are only allowed to order and approve dosages or changes in dosage schedule if the program in question has received prior approval from the State Opioid Treatment Authority or their designated alternate.
(4) Administering of narcotic agonist medications shall be performed by a registered nurse, licensed practical nurse, or other healthcare professional authorized by federal and state law to administer narcotic agonist medications under the direction and supervision of the program administrator.
(5) Dispensing services shall be provided under the direction and supervision of the program physician, provided that the agent is a pharmacist or other healthcare professional authorized under federal and state law to dispense narcotic agonist medications.
(6) The medical director shall assure that the program's medical services are in full compliance with the standards, ethics, and licensure requirements of the medical profession and these rules.
(7) The program shall adopt, maintain, and implement written procedures for acquiring patient physical examinations including medical histories and any laboratory tests or other special examination required by the medical director including the required content of those examinations and procedures. The medical director shall review and approve all such examination procedures. Physical examinations shall be completed before administering the first dose of an opioid agonist medication.
(8) The opioid treatment program shall adopt, maintain, and implement a policy and procedure to maintain the health and safety of patients and staff. This shall include:
(a) Control measures for infectious diseases such as hepatitis, tuberculosis, and AIDS;
(b) Informed consent for testing and medical treatment; and
(c) Medication monitoring.

Notes

Or. Admin. R. 415-020-0070
HR 4-1988, f. & cert. ef. 5-10-88; HR 17-1993, f. & cert. ef. 7-23-93, Renumbered from 410-006-0070; ADAP 3-1995, f. 12-1-95, cert. ef. 3-1-96; ADS 1-2003, f. 6-13-03, cert. ef. 7-1-03; ADS 2-2008, f. & cert. ef. 11-13-08; ADS 2-2021, temporary amend filed 09/21/2021, effective 10/01/2021 through 03/29/2022; ADS 3-2021, temporary amend filed 09/29/2021, effective 10/1/2021 through 3/29/2022; ADS 1-2022, amend filed 03/25/2022, effective 3/28/2022

Statutory/Other Authority: ORS 430.256

Statutes/Other Implemented: ORS 430.010(4)(b) & 430.560 - 430.590

The following state regulations pages link to this page.



State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.